Product Information
HYDRALAZINE 25 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0357 per EA under NDC 50111032701. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 1, 1984. Its Orange Book therapeutic-equivalence code is AA.
Strength
25 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
50111032701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDRALAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA088467FDA Approved
5/1/1984
TE Code
AA
On Market Since
9/30/1990
Pharmacological Classes
Price Statistics
The NADAC for HYDRALAZINE 25 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 59.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0357 per EA |
|---|---|
| All-time high | $0.0987 (Sep 10, 2014) |
| All-time low | $0.0260 (Nov 20, 2024) |
| 52-week high | $0.0375 |
| 52-week low | $0.0352 |
| Median price | $0.0419 |
| Average price | $0.0509 |
| Largest weekly change | -28.6% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydralazine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Arteriolar Vasodilator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDRALAZINE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDRALAZINE 25 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0357 per EA (NDC 50111032701), effective Sep 30, 2026.
How has the price of HYDRALAZINE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDRALAZINE 25 MG TABLET has declined 59.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDRALAZINE 25 MG TABLET?
Since Nov 28, 2013, the NADAC for HYDRALAZINE 25 MG TABLET has ranged from a low of $0.0260 (Nov 20, 2024) to a high of $0.0987 (Sep 10, 2014), with a median of $0.0419 per EA.
Are there cheaper alternatives to HYDRALAZINE 25 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDRALAZINE 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDRALAZINE 25 MG TABLET?
HYDRALAZINE 25 MG TABLET (NDC 50111032701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.